Gene · 719
Papers2,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| C3aR Antagonist Alleviates C3a Induced Tubular Profibrotic Phenotype Transition via Restoring PPARα/CPT-1α Mediated Mitochondrial Fatty Acid Oxidation in Renin-Dependent Hypertension. | Front Biosci (Landmark Ed) | 2023 | 37919077 | PubTator, text mining | PubMed |
| METTL3-mediated m6A methylation of C1qA regulates the Rituximab resistance of diffuse large B-cell lymphoma cells. | Cell Death Discov | 2023 | 37907575 | PubTator, text mining | PubMed |
| Utilizing Reduced Labeled Proton Clearance to Identify Preclinical Alzheimer Disease with 3D ASL MRI. | Case Rep Neurol | 2023 | 37901133 | PubTator, text mining | PubMed |
| Adjustment of p-value expression to ontology using machine learning for genetic prediction, prioritization, interaction, and its validation in glomerular disease. | Front Genet | 2023 | 37900183 | PubTator, text mining | PubMed |
| Clostridium butyricum Strain CCFM1299 Reduces Obesity via Increasing Energy Expenditure and Modulating Host Bile Acid Metabolism. | Nutrients | 2023 | 37892414 | PubTator, text mining | PubMed |
| Screening of potential biomarkers for polycystic ovary syndrome and identification of expression and immune characteristics. | PLoS One | 2023 | 37883387 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk RNA-sequencing reveals the poor prognostic value of ABCA1 in gastric adenocarcinoma. | Discov Oncol | 2023 | 37874419 | PubTator, text mining | PubMed |
| Prognostic Model and Tumor Immune Microenvironment Analysis of Complement-Related Genes in Gastric Cancer. | J Inflamm Res | 2023 | 37872955 | PubTator, text mining | PubMed |
| The Platelet Anaphylatoxin Receptor C5aR1 (CD88) Is a Promising Target for Modulating Vessel Growth in Response to Ischemia a. | TH Open | 2023 | 37868192 | PubTator, text mining | PubMed |
| Anaphylatoxin signaling activates macrophages to control intracellular Rickettsia proliferation. | Microbiol Spectr | 2023 | 37855623 | PubTator, text mining | PubMed |
| Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors. | Cell | 2023 | 37852260 | Swiss-Prot, curated | PubMed |
| The Role of Caspase-11 and Pyroptosis in the Regulation of Inflammation in Peri-Implantitis. | J Inflamm Res | 2023 | 37842190 | PubTator, text mining | PubMed |
| A Transcriptomic Severity Classifier IMX-SEV-3b to Predict Mortality in Intensive Care Unit Patients with COVID-19: A Prospective Observational Pilot Study. | J Clin Med | 2023 | 37834841 | PubTator, text mining | PubMed |
| Editorial: Bioinformatics applied to neuroscience. | Front Neurosci | 2023 | 37811331 | PubTator, text mining | PubMed |
| Gastric cancer metastasis-related NT5DC2 indicates unfavorable prognosis of patients. | Medicine (Baltimore) | 2023 | 37800836 | PubTator, text mining | PubMed |
| Identification of two immune subtypes and four hub immune-related genes in ovarian cancer through multiple analysis. | Medicine (Baltimore) | 2023 | 37800814 | PubTator, text mining | PubMed |
| Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies. | Front Immunol | 2023 | 37795086 | PubTator, text mining | PubMed |
| Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis. | Front Immunol | 2023 | 37795085 | PubTator, text mining | PubMed |
| Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. | Mol Cancer | 2023 | 37784082 | PubTator, text mining | PubMed |
| Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment. | J Immunother Cancer | 2023 | 37777251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/719/papers?page=12